50% Adherence is enough with modern ARVS, right - Terrence Blaschke, MD

International Workshop on Clinical Pharmacology on HIV, Hepatitis and Other Antiviral Drugs 2019

The ‘third wave’ of TB drug development what’s on the horizon (for patients with or without HIV) - Kelly Dooley, MD, PhD

International Workshop on Clinical Pharmacology on HIV, Hepatitis and Other Antiviral Drugs 2019

Efavirenz pharmacokinetics in HIV/TB coinfected persons initiating ART while receiving high dose rifapentine - Anthony Podany, PharmD

International Workshop on Clinical Pharmacology on HIV, Hepatitis and Other Antiviral Drugs 2019

In silico design of a microarray patch as a multipurpose prevention technology - Rajith Rajoli

International Workshop on Clinical Pharmacology on HIV, Hepatitis and Other Antiviral Drugs 2019

The initial Phase 1 evaluation of the safety, tolerability, and pharmacokinetics of GSK3640254 - Samit Joshi, MD

International Workshop on Clinical Pharmacology on HIV, Hepatitis and Other Antiviral Drugs 2019

Novel antiviral and immune targets to cure HBV - Fabien Zoulim, MD

International Workshop on Clinical Pharmacology on HIV, Hepatitis and Other Antiviral Drugs 2019

Improved long acting drug delivery: What are the technologies - Andrew Owen, BSc, MSc, PhD, FSB

International Workshop on Clinical Pharmacology on HIV, Hepatitis and Other Antiviral Drugs 2019

Long acting HIV drugs for treatment: Data and potential implementation - Charles Flexner, MD

International Workshop on Clinical Pharmacology on HIV, Hepatitis and Other Antiviral Drugs 2019

Long Acting HIV Drugs for Prevention: Data and Potential implementation - Laura Waters, MD

International Workshop on Clinical Pharmacology on HIV, Hepatitis and Other Antiviral Drugs 2019

Clinical Case Presentation - Catia Marzolini, PharmD, PhD

International Workshop on Clinical Pharmacology on HIV, Hepatitis and Other Antiviral Drugs 2019

Changes in drug interaction profiles for first-line HIV therapy over the 20 years of the Liverpool Drug Interaction website - Sara Gibbons

International Workshop on Clinical Pharmacology on HIV, Hepatitis and Other Antiviral Drugs 2019

Effect of CYP2b6 metabolizer status on levonorgestrel pharmacokinetics when combined with efavirenz-based antiretroviral therapy - Michelle Pham

International Workshop on Clinical Pharmacology on HIV, Hepatitis and Other Antiviral Drugs 2019

Drugs abuse and chemsex a new challenge for antiretroviral drug-drug interaction - Tess Martin

International Workshop on Clinical Pharmacology on HIV, Hepatitis and Other Antiviral Drugs 2019

Dual Maintenance for HIV: Con Perspective - Andrew Hill, MD

International Workshop on Clinical Pharmacology on HIV, Hepatitis and Other Antiviral Drugs 2019

Dual Maintenance for HIV: Pro Perspective - José Ramón Arribas, MD

International Workshop on Clinical Pharmacology on HIV, Hepatitis and Other Antiviral Drugs 2019

CRISPR/Cas and Gene Editing for HIV - Paula Cannon

International Workshop on Clinical Pharmacology on HIV, Hepatitis and Other Antiviral Drugs 2019

Dual Maintenance for HIV: Why Fix it if it's not Broken? (Debate: Discussion)

International Workshop on Clinical Pharmacology on HIV, Hepatitis and Other Antiviral Drugs 2019

Dual Maintenance for HIV: Why Fix it if it's not Broken? (Debate: Pro) - Jose Arribas

International Workshop on Clinical Pharmacology on HIV, Hepatitis and Other Antiviral Drugs 2019

Dual Maintenance for HIV: Why Fix it if it's not Broken? (Debate: Con) - Andrew Hill

International Workshop on Clinical Pharmacology on HIV, Hepatitis and Other Antiviral Drugs 2019

Clinical Case Presentation - Catia Marzolini

International Workshop on Clinical Pharmacology on HIV, Hepatitis and Other Antiviral Drugs 2019

Long-Acting HIV Drugs for Treatment: Data and Potential Implementation - Laura Waters

International Workshop on Clinical Pharmacology on HIV, Hepatitis and Other Antiviral Drugs 2019

Long-Acting HIV Drugs for Treatment: Data and Potential Implementation - Charles Flexner

International Workshop on Clinical Pharmacology on HIV, Hepatitis and Other Antiviral Drugs 2019

Improved Long-Acting Drug Delivery: What are the Technologies? - Andrew Owen

International Workshop on Clinical Pharmacology on HIV, Hepatitis and Other Antiviral Drugs 2019

Pharmacological Treatment of NASH - Sven Francque

International Workshop on Clinical Pharmacology on HIV, Hepatitis and Other Antiviral Drugs 2019